Quantbot Technologies LP Acquires New Position in Establishment Labs Holdings Inc. $ESTA

Quantbot Technologies LP bought a new position in Establishment Labs Holdings Inc. (NASDAQ:ESTA) in the second quarter, according to its most recent filing with the SEC. The firm bought 6,997 shares of the company’s stock, valued at approximately $600,000.

Other large investors also recently bought and sold shares of the company. KBC Group NV acquired a new stake in shares of Establishment Labs during the first quarter worth $28,000. Quarry LP acquired a new position in shares of Establishment Labs in the 3rd quarter valued at $34,000. Kestra Advisory Services LLC purchased a new position in Establishment Labs in the 4th quarter worth $47,000. Osaic Holdings Inc. raised its stake in Establishment Labs by 900.0% in the 2nd quarter. Osaic Holdings Inc. now owns 2,000 shares of the company’s stock worth $85,000 after acquiring an additional 1,800 shares during the last quarter. Finally, State of Wyoming acquired a new stake in Establishment Labs during the 2nd quarter worth about $87,000. Hedge funds and other institutional investors own 72.91% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on ESTA. TD Cowen increased their price objective on Establishment Labs from $95.00 to $117.00 and gave the company a “buy” rating in a report on Monday, August 3rd. Mizuho upped their target price on Establishment Labs from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Wednesday, July 15th. BTIG Research increased their price target on shares of Establishment Labs from $96.00 to $103.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Weiss Ratings reissued a “sell (e+)” rating on shares of Establishment Labs in a research report on Wednesday, June 24th. Finally, Needham & Company LLC lifted their price objective on shares of Establishment Labs from $86.00 to $95.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. Eight investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $100.25.

Establishment Labs Stock Down 0.9%

Shares of ESTA opened at $71.80 on Friday. The company has a market capitalization of $2.14 billion, a price-to-earnings ratio of -54.81 and a beta of 1.07. Establishment Labs Holdings Inc. has a 52 week low of $36.53 and a 52 week high of $97.59. The stock’s 50-day moving average price is $85.28 and its 200-day moving average price is $74.94. The company has a quick ratio of 2.52, a current ratio of 3.84 and a debt-to-equity ratio of 12.11.

Establishment Labs (NASDAQ:ESTA) last announced its quarterly earnings results on Thursday, August 6th. The company reported ($0.39) earnings per share for the quarter, missing the consensus estimate of ($0.34) by ($0.05). Establishment Labs had a negative net margin of 15.82% and a negative return on equity of 196.69%. The company had revenue of $67.54 million for the quarter, compared to analysts’ expectations of $65.79 million. During the same quarter in the prior year, the business posted ($0.57) earnings per share. The firm’s revenue was up 31.7% compared to the same quarter last year. On average, sell-side analysts predict that Establishment Labs Holdings Inc. will post -1.15 EPS for the current year.

Establishment Labs Company Profile

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.